Emicizumab prophylaxis to facilitate anticoagulant therapy for management of intra-atrial thrombosis in severe haemophilia with an inhibitor

Haemophilia. 2019 May;25(3):e203-e205. doi: 10.1111/hae.13721. Epub 2019 Mar 13.

Authors

Angela C Weyand¹, Adam L Dorfman², Jordan A Shavit¹, Steven W Pipe^{1

3}

Affiliations

¹ Department of Pediatrics, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan.
² Department of Pediatrics, Division of Cardiology, University of Michigan, Ann Arbor, Michigan.
³ Department of Pathology, University of Michigan, Ann Arbor, Michigan.

PMID: 30866130
DOI: 10.1111/hae.13721

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Bispecific / pharmacology*
Antibodies, Monoclonal, Humanized / pharmacology*
Anticoagulants / therapeutic use*
Child
Heart Atria / drug effects*
Hemophilia A / complications
Hemophilia A / drug therapy*
Hemophilia A / immunology*
Humans
Male
Thrombosis / complications*
Thrombosis / prevention & control*

Substances

Antibodies, Bispecific
Antibodies, Monoclonal, Humanized
Anticoagulants
emicizumab